In this roundup of recent podcast episodes, leading clinicians, advocates, and survivors share practical insights and personal experiences. From breaking down myths about non–muscle invasive bladder cancer to exploring newly approved treatments and the power of self-advocacy, these discussions are designed to help patients and caregivers feel informed and empowered. 1) Non-Muscle Invasive Bladder Cancer […]

How does your oncologist decide what bladder cancer treatment plan is best for you? Biomarkers are important clues that your care team relies on to guide your care. According to Fox Chase Cancer Center’s Dr. Elizabeth Plimack, biomarkers in bladder cancer generally fall into two important categories. One helps doctors understand whether a treatment is […]

Emerging research suggests that color vision deficiency, commonly called color blindness, may play an important role in how early bladder cancer is detected. A recent study explored whether people with color vision deficiency experience different survival outcomes after a cancer diagnosis compared with those without the condition. The findings were particularly striking for bladder cancer. […]

Is it possible to prepare your body before beginning bladder cancer treatment?  Emerging data points to yes. A growing body of research suggests that prehabilitation, targeted support before treatment, can help bladder cancer patients feel stronger, more prepared, and better equipped to recover, especially when facing intensive therapies like surgery. Simply put, prehabilitation means building […]

If you’ve recently been diagnosed with bladder cancer, you may have heard your doctor use terms like papillary or sessile to describe your tumor. What do these terms mean, and how does your tumor type inform your diagnosis? Let’s break down these terms: What do “papillary” and “sessile” mean? These adjectives describe the way the […]

A bladder cancer diagnosis often raises many questions. To help provide you with clear and patient-friendly answers, we recently spoke with Dr. Elizabeth Plimack, a leading medical oncologist at Fox Chase Cancer Center. Dr. Plimack’s primary focus is caring for people with genitourinary cancers with an interdisciplinary approach.  In this conversation, Dr. Plimack explains the […]

Neither Outcomes4Me nor any participants in or contributors to any webinar, article or content endorses or recommends any products or services. Consult your physician regarding any treatment or therapy. We sat down for a one-hour Q&A with Fox Chase Cancer Center’s Dr. Elizabeth Plimack, a leading expert in bladder cancer research and treatment. This session […]

Bladder cancer is the sixth most common cancer, and catching it early can make a big difference in treatment success. That’s where biomarker testing comes in. Biomarkers can give doctors important insights about what’s happening inside your cells. In bladder cancer, these markers can help with early detection, monitoring, and guiding treatment decisions. How biomarker […]

Before starting bladder cancer treatment, your care team needs to understand the extent the cancer has grown and whether it’s spread to other areas. This process is called staging and it’s an important step that provides a roadmap for choosing the safest and most effective approach for your diagnosis. Doctors use several tools to determine […]

Bladder cancer is the sixth most common cancer in the United States, with more than 83,000 new cases diagnosed each year. It occurs more often in men than women and is usually found in older adults, though it can happen at any age. The majority of cases are urothelial carcinoma, which begins in the cells […]